Sign inJoin waitlistJoin the waitlist

RT

Roni Tamari

Associate Attending Physician · New York Presbyterian Hospital

Credentials: · · · ·

History

New York Presbyterian Hospital
Present

Hematology and Medical Oncology
Montefiore Einstein
2004–2007
Memorial Sloan Kettering Cancer Center
2003–2004
Jacobi Medical Center
2000–2003
BEN GURION UNIV OF NEGEV, BEER-SHEVA
1996–2000

Research

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant
Science Translational Medicine · 2018 · 308 citations
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations
Blood · 2012 · 194 citations
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
Blood · 2013 · 148 citations

SG
Sergio Giralt
70 papers
MP
Miguel-Angel Perales
67 papers
AJ
Ann Jakubowski
55 papers
EP
Esperanza Papadopoulos
53 papers
BS
Brian Shaffer
43 papers
Christina Cho
38 papers · 7 as a fellow
Boglarka Gyurkocza
33 papers
DP
Doris Ponce
32 papers
HC
Hugo Castro-Malaspina
29 papers
PD
Parastoo Dahi
29 papers
Craig Sauter
28 papers
Juliet Barker
27 papers

Grants

Incidental Diagnosis of Clonal Hematopoiesis Among Healthy, Unrelated, Hematopoietic Stem Cell Donors: A Feasibility Study of Psychosocial, Ethical, and Clinical Issues
National Cancer Institute · R21
Contact PI · $433.9K · Sloan-Kettering Inst Can Research
2024–2027

Clinical trials

A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
Principal investigator · Withdrawn · Phase 2
Memorial Sloan Kettering Cancer Center
2026–2027
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
Principal investigator · Active not recruiting · Phase 1
Memorial Sloan Kettering Cancer Center
2018–2027
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Principal investigator · Recruiting
Memorial Sloan Kettering Cancer Center
2016–2027
T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
Principal investigator · Terminated · Phase 2
Memorial Sloan Kettering Cancer Center
2015–2017